Headline
Leona Knox
Bringing the patient perspective into cancer research priorities, unmet medical needs, and translational decision-making.
Keynote Speakers ⭐
World-class scientists, clinicians and patient advocates shaping the future of cancer research.
Keynote speakers at YS2C are not distant figures — they engage with early-career researchers through talks, discussion time and informal exchanges.
Why keynote speakers at YS2C?
YS2C is designed for high-level science — with real accessibility. Keynote speakers contribute vision, perspective and mentorship across disciplines.
Vision
Big-picture talks connecting fundamental biology, translational research and clinical impact.
Accessibility
Time for exchange: questions, discussion moments, and informal interactions during breaks.
Diversity of perspectives
From clinicians to patient advocates — because impact also means relevance and unmet needs.
2026 Keynote Speakers
The confirmed speakers list is updated as invitations are accepted.
Headline
Keynote
Florence Dalenc
One concise sentence on scientific focus and why it matters for the YS2C audience.
Keynote
Chris Marine
One concise sentence on the keynote’s angle: technology, clinical trials, tumor microenvironment, etc.
Keynote
Marta Kovatcheva
One concise sentence on the keynote’s angle: technology, clinical trials, tumor microenvironment, etc.
Keynote
Dafna Gold Melchior
One concise sentence on the keynote’s angle: technology, clinical trials, tumor microenvironment, etc.
Keynote
Firstname Lastname
One concise sentence on the keynote’s angle: technology, clinical trials, tumor microenvironment, etc.
Meet them in Toulouse
Join YS2C to interact directly with keynote speakers through talks, discussion time and informal exchanges.
